APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ketorolac Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ketorolac Injection Market Outlook and Growth Opportunities 2026

Report ID 174005650422 December 2025197 pages

Choose your research edition.

Industry ResearchKetorolac Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Ketorolac Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ketorolac Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ketorolac Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ketorolac Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ketorolac Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ketorolac Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ketorolac Injection market include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals and Athenex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ketorolac Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ketorolac Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ketorolac Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ketorolac Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Ketorolac Injection Segment by Company

Pfizer

Fresenius Kabi

Fosun Pharma (Gland Pharma)

Sagent Pharmaceuticals

Hikma

Lunan Pharma

Alvogen

Chengdu Brilliant Pharmaceuticals

Athenex

Sichuan Medcalo

Julphar Bangladesh Ltd.

Yung Shin Pharm

Tianjin Chase Sun Pharmaceutical

ZISKA Pharmaceuticals

Ketorolac Injection Segment by Concentration

15mg/ml

30mg/ml

Ketorolac Injection Segment by Application

Hospital

Clinics

Others

Ketorolac Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ketorolac Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ketorolac Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ketorolac Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Ketorolac Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ketorolac Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ketorolac Injection industry.

Chapter 3: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ketorolac Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ketorolac Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ketorolac Injection Industry Trends Table 2. Ketorolac Injection Industry Drivers Table 3. Ketorolac Injection Industry Opportunities and Challenges Table 4. Ketorolac Injection Industry Restraints Table 5. Global Ketorolac Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ketorolac Injection Revenue Share by Company (2021-2026) Table 7. Global Ketorolac Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ketorolac Injection Sales Volume Share by Company (2021-2026) Table 9. Global Ketorolac Injection Average Price (US$/K Units) of Company (2021-2026) Table 10. Global Ketorolac Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ketorolac Injection Key Company Manufacturing Base & Headquarters Table 12. Global Ketorolac Injection Company, Product Type & Application Table 13. Global Ketorolac Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ketorolac Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 15mg/ml Table 18. Significant Companies of 30mg/ml Table 19. Global Ketorolac Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Ketorolac Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Ketorolac Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Ketorolac Injection Sales Volume Share by Type (2021-2026) Table 23. Global Ketorolac Injection Sales Volume Share by Type (2027-2032) Table 24. Global Ketorolac Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ketorolac Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ketorolac Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ketorolac Injection Sales Value Share by Type (2021-2026) Table 28. Global Ketorolac Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinics Table 31. Significant Companies of Others Table 32. Global Ketorolac Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Ketorolac Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Ketorolac Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Ketorolac Injection Sales Volume Share by Application (2021-2026) Table 36. Global Ketorolac Injection Sales Volume Share by Application (2027-2032) Table 37. Global Ketorolac Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Ketorolac Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Ketorolac Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Ketorolac Injection Sales Value Share by Application (2021-2026) Table 41. Global Ketorolac Injection Sales Value Share by Application (2027-2032) Table 42. Global Ketorolac Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Ketorolac Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Ketorolac Injection Sales Market Share by Region (2021-2026) Table 45. Global Ketorolac Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Ketorolac Injection Sales Market Share by Region (2027-2032) Table 47. Global Ketorolac Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Ketorolac Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Ketorolac Injection Sales Value Share by Region (2021-2026) Table 50. Global Ketorolac Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Ketorolac Injection Sales Value Share by Region (2027-2032) Table 52. Global Ketorolac Injection Market Average Price (US$/K Units) by Region (2021-2026) Table 53. Global Ketorolac Injection Market Average Price (US$/K Units) by Region (2027-2032) Table 54. Global Ketorolac Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Ketorolac Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Ketorolac Injection Sales Market Share by Country (2021-2026) Table 58. Global Ketorolac Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Ketorolac Injection Sales Market Share by Country (2027-2032) Table 60. Global Ketorolac Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Ketorolac Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Ketorolac Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Ketorolac Injection Sales Value Market Share by Country (2027-2032) Table 64. Pfizer Company Information Table 65. Pfizer Business Overview Table 66. Pfizer Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 67. Pfizer Ketorolac Injection Product Portfolio Table 68. Pfizer Recent Development Table 69. Fresenius Kabi Company Information Table 70. Fresenius Kabi Business Overview Table 71. Fresenius Kabi Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 72. Fresenius Kabi Ketorolac Injection Product Portfolio Table 73. Fresenius Kabi Recent Development Table 74. Fosun Pharma (Gland Pharma) Company Information Table 75. Fosun Pharma (Gland Pharma) Business Overview Table 76. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 77. Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio Table 78. Fosun Pharma (Gland Pharma) Recent Development Table 79. Sagent Pharmaceuticals Company Information Table 80. Sagent Pharmaceuticals Business Overview Table 81. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 82. Sagent Pharmaceuticals Ketorolac Injection Product Portfolio Table 83. Sagent Pharmaceuticals Recent Development Table 84. Hikma Company Information Table 85. Hikma Business Overview Table 86. Hikma Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 87. Hikma Ketorolac Injection Product Portfolio Table 88. Hikma Recent Development Table 89. Lunan Pharma Company Information Table 90. Lunan Pharma Business Overview Table 91. Lunan Pharma Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 92. Lunan Pharma Ketorolac Injection Product Portfolio Table 93. Lunan Pharma Recent Development Table 94. Alvogen Company Information Table 95. Alvogen Business Overview Table 96. Alvogen Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 97. Alvogen Ketorolac Injection Product Portfolio Table 98. Alvogen Recent Development Table 99. Chengdu Brilliant Pharmaceuticals Company Information Table 100. Chengdu Brilliant Pharmaceuticals Business Overview Table 101. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 102. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio Table 103. Chengdu Brilliant Pharmaceuticals Recent Development Table 104. Athenex Company Information Table 105. Athenex Business Overview Table 106. Athenex Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 107. Athenex Ketorolac Injection Product Portfolio Table 108. Athenex Recent Development Table 109. Sichuan Medcalo Company Information Table 110. Sichuan Medcalo Business Overview Table 111. Sichuan Medcalo Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 112. Sichuan Medcalo Ketorolac Injection Product Portfolio Table 113. Sichuan Medcalo Recent Development Table 114. Julphar Bangladesh Ltd. Company Information Table 115. Julphar Bangladesh Ltd. Business Overview Table 116. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 117. Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio Table 118. Julphar Bangladesh Ltd. Recent Development Table 119. Yung Shin Pharm Company Information Table 120. Yung Shin Pharm Business Overview Table 121. Yung Shin Pharm Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 122. Yung Shin Pharm Ketorolac Injection Product Portfolio Table 123. Yung Shin Pharm Recent Development Table 124. Tianjin Chase Sun Pharmaceutical Company Information Table 125. Tianjin Chase Sun Pharmaceutical Business Overview Table 126. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 127. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio Table 128. Tianjin Chase Sun Pharmaceutical Recent Development Table 129. ZISKA Pharmaceuticals Company Information Table 130. ZISKA Pharmaceuticals Business Overview Table 131. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 132. ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio Table 133. ZISKA Pharmaceuticals Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Ketorolac Injection Distributors List Table 137. Ketorolac Injection Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Ketorolac Injection Product Image Figure 2. Global Ketorolac Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ketorolac Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ketorolac Injection Sales (2021-2032) & (K Units) Figure 5. Global Ketorolac Injection Sales Average Price (US$/K Units) & (2021-2032) Figure 6. Global Ketorolac Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 15mg/ml Image Figure 10. 30mg/ml Image Figure 11. Global Ketorolac Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Ketorolac Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ketorolac Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Ketorolac Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ketorolac Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ketorolac Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Ketorolac Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Ketorolac Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Ketorolac Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Ketorolac Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Ketorolac Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Ketorolac Injection Sales Value Share by Application (2021-2032) Figure 26. Global Ketorolac Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Ketorolac Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Ketorolac Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Ketorolac Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Ketorolac Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Ketorolac Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Ketorolac Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Ketorolac Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Ketorolac Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Ketorolac Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Ketorolac Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Ketorolac Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Ketorolac Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Ketorolac Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Ketorolac Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Ketorolac Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Ketorolac Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Ketorolac Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Ketorolac Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg/ml
  • 30mg/ml
Applications
  • Hospital
  • Clinics
  • Others
Companies covered
  • Pfizer
  • Fresenius Kabi
  • Fosun Pharma (Gland Pharma)
  • Sagent Pharmaceuticals
  • Hikma
  • Lunan Pharma
  • Alvogen
  • Chengdu Brilliant Pharmaceuticals
  • Athenex
  • Sichuan Medcalo
  • Julphar Bangladesh Ltd.
  • Yung Shin Pharm
  • Tianjin Chase Sun Pharmaceutical
  • ZISKA Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ketorolac Injection Sales Value (2021-2032)
  4. 1.2.2 Global Ketorolac Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Ketorolac Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ketorolac Injection Market Dynamics
  1. 2.1 Ketorolac Injection Industry Trends
  2. 2.2 Ketorolac Injection Industry Drivers
  3. 2.3 Ketorolac Injection Industry Opportunities and Challenges
  4. 2.4 Ketorolac Injection Industry Restraints
3 Ketorolac Injection Market by Company
  1. 3.1 Global Ketorolac Injection Company Revenue Ranking in 2025
  2. 3.2 Global Ketorolac Injection Revenue by Company (2021-2026)
  3. 3.3 Global Ketorolac Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Ketorolac Injection Average Price by Company (2021-2026)
  5. 3.5 Global Ketorolac Injection Company Ranking (2024-2026)
  6. 3.6 Global Ketorolac Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Ketorolac Injection Company Product Type and Application
  8. 3.8 Global Ketorolac Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ketorolac Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ketorolac Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ketorolac Injection Market by Type
  1. 4.1 Ketorolac Injection Type Introduction
  2. 4.1.1 15mg/ml
  3. 4.1.2 30mg/ml
  4. 4.2 Global Ketorolac Injection Sales Volume by Type
  5. 4.2.1 Global Ketorolac Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ketorolac Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ketorolac Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ketorolac Injection Sales Value by Type
  9. 4.3.1 Global Ketorolac Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ketorolac Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ketorolac Injection Sales Value Share by Type (2021-2032)
5 Ketorolac Injection Market by Application
  1. 5.1 Ketorolac Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Ketorolac Injection Sales Volume by Application
  6. 5.2.1 Global Ketorolac Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ketorolac Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ketorolac Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ketorolac Injection Sales Value by Application
  10. 5.3.1 Global Ketorolac Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ketorolac Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ketorolac Injection Sales Value Share by Application (2021-2032)
6 Ketorolac Injection Regional Sales and Value Analysis
  1. 6.1 Global Ketorolac Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ketorolac Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Ketorolac Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Ketorolac Injection Sales by Region (2027-2032)
  5. 6.3 Global Ketorolac Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ketorolac Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ketorolac Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ketorolac Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Ketorolac Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ketorolac Injection Sales Value (2021-2032)
  12. 6.6.2 North America Ketorolac Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ketorolac Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Ketorolac Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ketorolac Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ketorolac Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ketorolac Injection Sales Value (2021-2032)
  21. 6.9.2 South America Ketorolac Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ketorolac Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ketorolac Injection Sales Value Share by Country, 2025 VS 2032
7 Ketorolac Injection Country-level Sales and Value Analysis
  1. 7.1 Global Ketorolac Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ketorolac Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ketorolac Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Ketorolac Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Ketorolac Injection Sales by Country (2027-2032)
  6. 7.4 Global Ketorolac Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ketorolac Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ketorolac Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ketorolac Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ketorolac Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ketorolac Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ketorolac Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ketorolac Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ketorolac Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ketorolac Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ketorolac Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ketorolac Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ketorolac Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ketorolac Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ketorolac Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ketorolac Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ketorolac Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ketorolac Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ketorolac Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ketorolac Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ketorolac Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ketorolac Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ketorolac Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ketorolac Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ketorolac Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ketorolac Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ketorolac Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ketorolac Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ketorolac Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ketorolac Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ketorolac Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ketorolac Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ketorolac Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Ketorolac Injection Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Fresenius Kabi
  8. 8.2.1 Fresenius Kabi Company Information
  9. 8.2.2 Fresenius Kabi Business Overview
  10. 8.2.3 Fresenius Kabi Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
  12. 8.2.5 Fresenius Kabi Recent Developments
  13. 8.3 Fosun Pharma (Gland Pharma)
  14. 8.3.1 Fosun Pharma (Gland Pharma) Company Information
  15. 8.3.2 Fosun Pharma (Gland Pharma) Business Overview
  16. 8.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
  18. 8.3.5 Fosun Pharma (Gland Pharma) Recent Developments
  19. 8.4 Sagent Pharmaceuticals
  20. 8.4.1 Sagent Pharmaceuticals Company Information
  21. 8.4.2 Sagent Pharmaceuticals Business Overview
  22. 8.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
  24. 8.4.5 Sagent Pharmaceuticals Recent Developments
  25. 8.5 Hikma
  26. 8.5.1 Hikma Company Information
  27. 8.5.2 Hikma Business Overview
  28. 8.5.3 Hikma Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hikma Ketorolac Injection Product Portfolio
  30. 8.5.5 Hikma Recent Developments
  31. 8.6 Lunan Pharma
  32. 8.6.1 Lunan Pharma Company Information
  33. 8.6.2 Lunan Pharma Business Overview
  34. 8.6.3 Lunan Pharma Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
  36. 8.6.5 Lunan Pharma Recent Developments
  37. 8.7 Alvogen
  38. 8.7.1 Alvogen Company Information
  39. 8.7.2 Alvogen Business Overview
  40. 8.7.3 Alvogen Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Alvogen Ketorolac Injection Product Portfolio
  42. 8.7.5 Alvogen Recent Developments
  43. 8.8 Chengdu Brilliant Pharmaceuticals
  44. 8.8.1 Chengdu Brilliant Pharmaceuticals Company Information
  45. 8.8.2 Chengdu Brilliant Pharmaceuticals Business Overview
  46. 8.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
  48. 8.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments
  49. 8.9 Athenex
  50. 8.9.1 Athenex Company Information
  51. 8.9.2 Athenex Business Overview
  52. 8.9.3 Athenex Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Athenex Ketorolac Injection Product Portfolio
  54. 8.9.5 Athenex Recent Developments
  55. 8.10 Sichuan Medcalo
  56. 8.10.1 Sichuan Medcalo Company Information
  57. 8.10.2 Sichuan Medcalo Business Overview
  58. 8.10.3 Sichuan Medcalo Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
  60. 8.10.5 Sichuan Medcalo Recent Developments
  61. 8.11 Julphar Bangladesh Ltd.
  62. 8.11.1 Julphar Bangladesh Ltd. Company Information
  63. 8.11.2 Julphar Bangladesh Ltd. Business Overview
  64. 8.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
  66. 8.11.5 Julphar Bangladesh Ltd. Recent Developments
  67. 8.12 Yung Shin Pharm
  68. 8.12.1 Yung Shin Pharm Company Information
  69. 8.12.2 Yung Shin Pharm Business Overview
  70. 8.12.3 Yung Shin Pharm Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
  72. 8.12.5 Yung Shin Pharm Recent Developments
  73. 8.13 Tianjin Chase Sun Pharmaceutical
  74. 8.13.1 Tianjin Chase Sun Pharmaceutical Company Information
  75. 8.13.2 Tianjin Chase Sun Pharmaceutical Business Overview
  76. 8.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
  78. 8.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments
  79. 8.14 ZISKA Pharmaceuticals
  80. 8.14.1 ZISKA Pharmaceuticals Company Information
  81. 8.14.2 ZISKA Pharmaceuticals Business Overview
  82. 8.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
  84. 8.14.5 ZISKA Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ketorolac Injection Value Chain Analysis
  2. 9.1.1 Ketorolac Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ketorolac Injection Sales Mode & Process
  6. 9.2 Ketorolac Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ketorolac Injection Distributors
  9. 9.2.3 Ketorolac Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst